Pharma & Health Care

Evonik offers a broad, versatile portfolio of functional excipients, performance boosters, drug delivery technologies and contract development and manufacturing (CDMO) services for the pharmaceutical and healthcare industry. As a trusted partner to the top life-science companies, we are dedicated to advancing drug development and performance, expediting market access, and ensuring supply security.

Our oral drug delivery solutions are built on a six-decade legacy, marked by our flagship EUDRAGIT® polymers that cater to complex release profiles for oral solid dosage forms. These highly adaptable excipients align seamlessly with core oral drug delivery processes and are available in diverse forms to facilitate ease of handling and scalability. Our EUDRACAP® pre-locked, ready-to-fill capsules ensure precise pH targeting for the delivery of drugs to the mid-to-upper small intestine and colon.

In parenteral drug delivery, Evonik is a leading CDMO, specializing in complex formulations such as lipid- and polymer-based systems. Our RESOMER® and LACTEL® bioresorbable polymers are renowned for their safety and biocompatibility, essential for extended-release parenteral applications. Our Health Care business excels in lipid formulations for a diverse range of therapeutics, including nucleic acids, small molecules, peptides, and proteins, ensuring our customers' drug development journey is seamless and efficient.

Evonik's PhytoChol® Inject offers customers a high-purity, plant-based cholesterol for parenteral applications. This innovative product meets the growing demand for non-animal-derived materials, ensuring supply reliability and compliance with stringent regulatory standards.

Our Drug Substance unit within Evonik’s Health Care business encompasses the company’s contract development and manufacturing organization (CDMO) services for active pharmaceutical ingredients (APIs), including large-scale high potency APIs and multi-step complex APIs.

For the synthesis of pharmaceutical compounds, our PERSYNT® portfolio ensures efficiency and precision. The Metalyst® series of activated metal catalysts are essential in hydrogenation reactions, a critical step in the synthesis of various pharmaceuticals. Noblyst® P Catalysts can be used for protection group removal in the synthesis of pharmaceutical compounds. CHROMATOCEL® Chromatographic Media gels are designed for removing impurities in organic solvents, ensuring high purity and quality in the final pharmaceutical products.

For the biopharmaceuticals industry, our cQrex® range of peptides, amino acids, carbohydrates, and plant-based cholesterol PhytoChol® Biopharma, enable partners throughout the entire value chain, from development to commercial production, to successful and quickly bring their biologics, cell and gene therapies to market.

Evonik's broad portfolio for the pharmaceutical and healthcare industry addresses the full spectrum of drug development and manufacturing challenges. From drug delivery systems to synthesis and purification, Evonik delivers reliability and innovation, contributing to the advancement of healthcare and the well-being of patients worldwide.